Xiangxue Pharmaceutical (300147.SZ): Court rules to accept the company's reorganization; stock is subject to additional delisting risk warning

date
21:04 19/11/2026
avatar
GMT Eight
*ST Xiangxue (300147.SZ) announced that on November 19, 2026, the company received a Civil Ruling served by the Guangzhou Intermediate People's Court of Guangdong Province (the "Guangzhou Intermediate Court"). The Guangzhou Intermediate Court ruled to accept the reorganization applications filed against the company by its creditors, Guangzhou Rural Commercial Bank Co., Ltd. Huangpu Branch and Guangzhou High-tech Zone Financial Leasing Co., Ltd., and designated King & Wood Mallesons (Guangzhou) Law Firm (lead institution) and Guangdong Orient Kunlun Law Firm as the company's administrators.
Xiangxue Pharmaceutical (300147.SZ) announced that on November 19, 2026, the company received a civil ruling served by the Guangzhou Intermediate People's Court of Guangdong Province (the "Guangzhou Intermediate Court"). The Guangzhou Intermediate Court ruled to accept the reorganization applications filed against the company by its creditors Guangzhou Rural Commercial Bank Co., Ltd. Huangpu Branch and Guangzhou High-tech Zone Financial Leasing Co., Ltd., and designated King & Wood Mallesons (Guangzhou) (lead institution) and Guangdong Dongfang Kunlun Law Firm as the company's administrators. Because the Guangzhou Intermediate Court has ruled in accordance with law to accept the creditors' reorganization application against the company, pursuant to the relevant provisions of Article 10.4.1 of the Shenzhen Stock Exchange ChiNext Stock Listing Rules, the company's stock trading will be subject to an additional delisting risk warning starting November 20, 2026. This additional implementation of the delisting risk warning does not require a trading halt; the company's stock abbreviation remains "Xiangxue Pharmaceutical," the securities code remains "300147," and the daily price limit for the company's stock remains "20%." After the court ruled that the company has entered reorganization proceedings, the company still faces the risk of being declared bankrupt if the reorganization fails. If subsequently declared bankrupt, the company will undergo bankruptcy liquidation, and in accordance with relevant provisions, the company's stock will face the risk of termination of listing.